1. Home
  2. WNEB vs TNDM Comparison

WNEB vs TNDM Comparison

Compare WNEB & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNEB
  • TNDM
  • Stock Information
  • Founded
  • WNEB 1853
  • TNDM 2006
  • Country
  • WNEB United States
  • TNDM United States
  • Employees
  • WNEB N/A
  • TNDM 2650
  • Industry
  • WNEB Savings Institutions
  • TNDM Medical/Dental Instruments
  • Sector
  • WNEB Finance
  • TNDM Health Care
  • Exchange
  • WNEB Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • WNEB N/A
  • TNDM 1.1B
  • IPO Year
  • WNEB N/A
  • TNDM 2013
  • Fundamental
  • Price
  • WNEB $8.55
  • TNDM $16.86
  • Analyst Decision
  • WNEB Buy
  • TNDM Buy
  • Analyst Count
  • WNEB 3
  • TNDM 16
  • Target Price
  • WNEB $9.75
  • TNDM $44.44
  • AVG Volume (30 Days)
  • WNEB 60.6K
  • TNDM 1.5M
  • Earning Date
  • WNEB 04-29-2025
  • TNDM 04-30-2025
  • Dividend Yield
  • WNEB 3.28%
  • TNDM N/A
  • EPS Growth
  • WNEB N/A
  • TNDM N/A
  • EPS
  • WNEB 0.56
  • TNDM N/A
  • Revenue
  • WNEB $73,385,000.00
  • TNDM $940,203,000.00
  • Revenue This Year
  • WNEB N/A
  • TNDM $8.59
  • Revenue Next Year
  • WNEB $8.18
  • TNDM $10.87
  • P/E Ratio
  • WNEB $15.32
  • TNDM N/A
  • Revenue Growth
  • WNEB N/A
  • TNDM 25.74
  • 52 Week Low
  • WNEB $6.00
  • TNDM $15.75
  • 52 Week High
  • WNEB $10.08
  • TNDM $53.69
  • Technical
  • Relative Strength Index (RSI)
  • WNEB 46.99
  • TNDM 33.57
  • Support Level
  • WNEB $7.73
  • TNDM $16.30
  • Resistance Level
  • WNEB $8.49
  • TNDM $17.73
  • Average True Range (ATR)
  • WNEB 0.44
  • TNDM 1.11
  • MACD
  • WNEB -0.00
  • TNDM 0.28
  • Stochastic Oscillator
  • WNEB 49.20
  • TNDM 29.92

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: